Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

A study has found a previously known cancer-related drug can also help slow down the symptoms of Parkinson's disease, but ...

A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.

Researchers have created a detailed map of chemical modifications to DNA that occur in the human brain from the earliest ...

Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Autism Spectrum Disorder is a complex condition with rising global prevalence. Research indicates it stems from a blend of genetic predispositions and ...

About BB-301 BB-301 is a novel, modified AAV9 capsid expressing ... focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary “Silence and Replace ...

Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has ...

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...